KalVista Pharmaceuticals ... (KALV)
10.85
-0.54 (-4.78%)
At close: Mar 03, 2025, 3:59 PM
10.87
0.18%
After-hours: Mar 03, 2025, 04:00 PM EST
KalVista Pharmaceuticals Ratios Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| PE Ratio | -3.3 | -3.31 | -4.55 | -10.72 | -6.65 | -16.66 | -6.28 | -3.79 | -4.27 | -12.61 | -9.94 | -27.48 |
| PEG Ratio | -0.12 | 0.77 | -0.23 | -0.25 | -0.35 | 1.70 | 0.31 | 0.19 | 0.07 | 0.59 | -0.06 | n/a |
| PS Ratio | n/a | n/a | n/a | 37.57 | 15.26 | 21.51 | 11.83 | 46.82 | 22.92 | 50.50 | 135.95 | 36.68 |
| PB Ratio | 2.02 | 1.54 | 1.68 | 1.85 | 2.31 | 3.59 | 3.64 | 2.25 | 2.27 | -2.06 | -1.67 | -1.99 |
| P/FCF Ratio | -4.66 | -3.24 | -3.94 | -15.76 | -4.3 | -9.26 | 10.87 | -2.96 | -3.71 | -14.03 | -11.57 | -29.29 |
| P/OCF Ratio | -4.68 | -3.29 | -3.99 | -15.8 | -4.32 | -9.54 | 9.40 | -2.97 | -3.72 | -14.31 | -11.61 | -30.75 |
| OCF/S Ratio | n/a | n/a | n/a | -2.38 | -3.53 | -2.25 | 1.26 | -15.77 | -6.17 | -3.53 | -11.71 | -1.19 |
| Debt / Equity Ratio | 0.04 | 0.05 | 0.04 | 0.02 | 0.02 | 0.00 | 0.01 | n/a | 0.21 | -0.15 | -0.09 | -0.09 |
| Quick Ratio | 9.90 | 11.46 | 16.49 | 27.04 | 11.49 | 6.40 | 2.56 | 11.35 | 7.59 | 0.65 | 2.51 | 2.71 |
| Current Ratio | 9.90 | 11.46 | 16.73 | 27.04 | 11.49 | 6.40 | 2.56 | 11.35 | 7.59 | 0.65 | 2.51 | 2.71 |
| Asset Turnover | n/a | n/a | n/a | 0.05 | 0.14 | 0.14 | 0.14 | 0.04 | 0.09 | 0.27 | 0.04 | 0.18 |
| Interest Coverage | n/a | n/a | -88.64 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -12.88 | -7.16 |
| Return on Equity (ROE) | -0.61 | -0.46 | -0.37 | -0.17 | -0.35 | -0.22 | -0.58 | -0.59 | -0.53 | 0.16 | 0.17 | 0.07 |
| Return on Assets (ROA) | -0.54 | -0.41 | -0.34 | -0.16 | -0.31 | -0.18 | -0.26 | -0.54 | -0.46 | -1.09 | -0.56 | -0.24 |
| Return on Capital (ROIC) | -0.66 | -0.66 | -0.5 | -0.22 | -0.48 | -0.3 | -0.49 | -0.71 | -0.71 | 18.02 | -0.85 | -0.34 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | n/a | n/a | 94.87% | 99.68% | 99.78% | 99.78% | 99.16% | 99.31% | 99.54% | 100.00% | 100.00% |
| Net Profit Margin | n/a | n/a | n/a | -350.62% | -229.44% | -129.08% | -188.29% | -1.24K% | -536.15% | -400.55% | -1.37K% | -133.49% |
| Pretax Profit Margin | n/a | n/a | n/a | -364.41% | -230.42% | -128.31% | -188.29% | -1.24K% | -536.15% | -400.55% | -1.37K% | -133.49% |
| Operating Profit Margin | n/a | n/a | n/a | -456.45% | -319.41% | -184.91% | -222.84% | -1.49K% | -711.72% | -448.39% | -1.26K% | -119.18% |
| FCF Margin | n/a | n/a | n/a | -238.4% | -354.89% | -232.19% | 108.78% | -1.58K% | -617.3% | -359.92% | -1.17K% | -125.23% |
| EBITDA Margin | n/a | n/a | n/a | -359.28% | -315.37% | -182.56% | -220.69% | -1.48K% | -710.17% | -446.29% | -1.26K% | -114.37% |